Words of wisdom. Re: Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial. Escudier B, Pluzanska A, Koralewski P, et al., for the AVOREN Trial investigators.

Overview

authors

Shariat, Shahrokh
Bolenz, Christian
Karakiewicz, Pierre I

publication date

October 1, 2008

published in

European urology Journal

Identity

Scopus Document Identifier

58249093739

Digital Object Identifier (DOI)

10.1016/j.eururo.2008.07.026

PubMed ID

18953756

Additional Document Info

has global citation frequency

2

volume

54

issue

4